PMC:7696151 / 114593-114959 2 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T768 | 0-366 | Sentence | denotes | Abd-Elsalam, et al. (2020) [36] Multicenter, randomized controlled trial194 COVID-19 infected patients HCQ group -> SOC+ HCQ (400 mg twice daily, on day 1, followed by 200 mg tablets twice daily)Control group -> SOC4 weeks of treatment There was no significant difference between the two groups regarding any laboratory parameters or the baseline characteristics. |